Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Eur.r Regulatory News (SERE)

Share Price Information for Schroder Eur.r (SERE)

Share Price is delayed by 15 minutes
Get Live Data
59.80    0.20 (0.34%)
Bid:
59.40
Ask:
60.00
Spread: 0.60 (1.01%)
Market Cap: £78.58m
SERE Live PriceLast checked at - London Stock Exchange

Intraday Schroder Eur.r Share Chart

Results analysis from Kepler Trust Intelligence

12 Dec 2024 09:55

RNS Number : 8711P
Schroder Eur Real Est Inv Trust PLC
12 December 2024
 

Schroder European Real Estate (SERE)

12/12/2024

Results analysis from Kepler Trust Intelligence

Schroder European Real Estate has reported a NAV total return of 0.4% for the year ending 30/09/2024, having paid dividends per share of 5.92 euro cents. The dividend was 103% covered by EPRA earnings, which were up 3% on the previous year thanks to rental growth outpacing interest costs.

Dividends offset a decline in the portfolio value of 3.6%, due primarily to outward yield movement in the first half of the year. The manager notes that recent evidence suggests a stabilisation of values, and has observed an increase in investment volumes for smaller lot sizes in desirable cities.

During the year, the company strengthened its balance sheet, completing all near-term refinancings which means the average interest cost is just 3.2%. No debt is due to expire until June 2025.

The loan-to-value is a modest 25% net of cash, and the manager has c. €25 million of cash available for investment or other uses. Management is working on the disposal of Seville, which if successful, will reduce gearing to 22% net of cash.

Over the period, SERE's discount has narrowed but still stands at an attractive c. 33%. This compares to a c. 21% average for the AIC Property - Europe sector and 22% for the AIC Property - UK Commercial sector.

Kepler View

Schroder European Real Estate's (SERE) main attraction is the high yield which is magnified by the current wide discount. The fully-covered dividend would equate to a c. 7.2% yield on the share price at the time of writing. This is backed by a portfolio which is 96% occupied, and after 100% of rent due was collected for the year. Management completed 16 new leases or re-gears over the 12 months under review with a weighted average life of 8 years.

A small decline in the value of the property portfolio over the period was expected and modest, but hopefully reflects the end of a tough period for real estate amid high inflation and interest rates. Almost all the write-down was taken in the first half ending in March, which therefore pre-dates the ECB's rate cuts which began in June and have taken the key lending rate from 4.5% to 3.4%. It is encouraging to hear from the manager his observations that a pick up in activity seems underway, and further rate cuts are widely expected which should improve the backdrop even more.

There are concerns around the outlook for European economies, but SERE should benefit from a relatively defensive positioning in high quality locations and properties. Approximately 33% of the portfolio by value is offices, which are in supply-constrained locations and leased off affordable rents. The industrial exposure of 30% is a mixture of distribution warehouses and light industrial accommodation in growth cities within France and The Netherlands. The retail exposure is limited to 17% and comprises DIY and grocery investments rather than fashion and other discretionary sectors. SERE also has 9% of the portfolio allocated to the alternatives sector, comprising a mixed-use data centre and a car showroom. Substantial cash on the balance sheet provides firepower for asset management initiatives, buybacks or other measures.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAKLLBFZLLEFBL
Date   Source Headline
3rd Jun 20262:30 pmRNSNotice of Results
14th Apr 20267:00 amRNSProperty Portfolio Valuation
13th Apr 20262:30 pmRNSDividend Currency Exchange Rate (Sterling)
24th Mar 20263:30 pmRNSDirector/PDMR Shareholding
24th Mar 20262:30 pmRNSDividend Currency Exchange Rate (SA Rand)
19th Mar 20267:00 amRNSAnnouncement of NAV and Quarterly Dividend
17th Mar 20263:00 pmRNSResult of AGM
5th Mar 20267:00 amRNSAsset Management Update
13th Jan 20262:30 pmRNSDividend Currency Exchange Rate (Sterling)
8th Jan 20267:00 amRNSProperty Portfolio Valuation
16th Dec 202512:16 pmRNSKPN Formal Notice to Terminate Lease
10th Dec 20253:00 pmRNSAnnual Financial Report on NSM
10th Dec 20252:30 pmRNSDividend Currency Exchange Rate (SA Rand)
9th Dec 202510:16 amRNS-RResults analysis from Kepler Trust Intelligence
5th Dec 20257:02 amRNSNotice of AGM
5th Dec 20257:01 amRNSDividend Declaration
5th Dec 20257:00 amRNSFinal Results
26th Nov 20257:00 amRNSDirectorate change
7th Nov 20252:30 pmRNSNotice of Results
16th Oct 20257:00 amRNS-RKepler Trust Intelligence: New Research
9th Oct 20257:00 amRNSProperty Portfolio Valuation
6th Oct 20252:30 pmRNSDividend Currency Exchange Rate (Sterling)
1st Oct 20253:30 pmRNSTotal Voting Rights
16th Sep 20252:30 pmRNSDividend Currency Exchange Rate (SA Rand)
12th Sep 20257:00 amRNSAnnouncement of NAV and Quarterly Dividend
3rd Sep 20257:30 amRNSTransaction in Own Shares
2nd Sep 20257:30 amRNSTransaction in Own Shares
1st Sep 20257:31 amRNSTotal Voting Rights
1st Sep 20257:30 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSHolding(s) in Company
23rd Jul 20254:45 pmRNSHolding(s) in Company
21st Jul 20252:30 pmRNSDividend Currency Exchange Rate (Sterling)
15th Jul 20257:30 amRNSHolding(s) in Company
11th Jul 20257:00 amRNSProperty Portfolio Valuation
4th Jul 202511:48 amRNS-RResults analysis from Kepler Trust Intelligence
2nd Jul 20252:30 pmRNSDividend Currency Exchange Rate (SA Rand)
26th Jun 20257:01 amRNSDividend Declaration
26th Jun 20257:00 amRNSHalf-year Report
5th Jun 20252:30 pmRNSNotice of Results
2nd Jun 20257:30 amRNSTotal Voting Rights
22nd May 20257:00 amRNSMajor Lease Renewal Secured at Berlin Investment
16th May 20257:30 amRNSTransaction in Own Shares
13th May 20257:30 amRNSTransaction in Own Shares
12th May 20257:30 amRNSTransaction in Own Shares
1st May 202511:24 amRNSTotal Voting Rights
28th Apr 20257:30 amRNSTransaction in Own Shares
24th Apr 20257:30 amRNSTransaction in Own Shares
22nd Apr 20257:30 amRNSTransaction in Own Shares
17th Apr 20257:30 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSProperty Portfolio Valuation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.